Literature DB >> 9384508

ATP, a partial agonist for the P2Z receptor of human lymphocytes.

C E Gargett1, J E Cornish, J S Wiley.   

Abstract

1. Although extracellular adenosine 5'-triphosphate (ATP) is the natural ligand for the P2Z receptor of human lymphocytes it is less potent than 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) in opening the associated ion channel, which conducts a range of permeants including Ba2+ and ethidium+. We have quantified the influx of ethidium+ into lymphocytes produced by BzATP, ATP, 2-methylthio-ATP (2MeSATP) and ATPgammaS, studied competition between ATP and BzATP and investigated the effects of KN-62, a new and potent inhibitor of the P2Z receptor. 2. BzATP and ATP stimulated ethidium+ influx with EC50 values of 15.4+/-1.4 microM (n=5) and 85.6+/-8.8 microM (n=5), respectively. The maximal response to ATP was only 69.8+/-1.9% of that for BzATP. Hill analysis gave nH of 3.17+/-0.24 (n=3) and 2.09+/-0.45 (n=4) for BzATP and ATP, suggesting greater positive cooperativity for BzATP than for ATP in opening the P2Z receptor-operated ion channel. 3. A rank order of agonist potency of BzATP>ATP=2MeSATP>ATPgammaS was observed for agonist-stimulated ethidium+ influx, while maximal influxes followed a rank order of BzATP>ATP>2MeSATP>ATPgammaS. 4. Preincubation with 30-50 microM oxidized ATP (ox-ATP), an irreversible P2Z inhibitor, reduced the maximal response but did not change the steepness of the Ba2+ influx-response curve produced by BzATP (nH 3.2 and 2.9 for 30 and 50 microM ox-ATP, respectively (n=2)). 5. ATP (300-1000 microM) added simultaneously with 30 microM BzATP (EC90) inhibited both ethidium+ and Ba2+ fluxes to a maximum of 30-40% relative to the values observed with BzATP alone. Moreover, ATP (300 microM) shifted the concentration-response curve to the right for BzATP-stimulated Ba2+ influx, confirming competition between ATP and BzATP. 6. KN-62, a new and powerful inhibitor of the lymphocyte P2Z receptor, showed less potency in antagonizing BzATP-mediated fluxes than ATP-induced fluxes when maximal concentrations of both agonists (BzATP, 50 microM; ATP, 500 microM) were used. 7. These data suggest that the natural ligand, ATP, is a partial agonist for the P2Z receptor while BzATP is a more efficacious agonist. Moreover the competitive studies show that only a single class of P2-receptor (P2Z class) is expressed on human leukaemic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9384508      PMCID: PMC1565004          DOI: 10.1038/sj.bjp.0701447

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  ATP-induced [Ca(2+)](i) changes and depolarization in GH3 cells.

Authors:  H S Chung; K S Park; S K Cha; I D Kong; J W Lee
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Large-conductance channel formation mediated by P2X7 receptor activation is regulated through distinct intracellular signaling pathways in peritoneal macrophages and 2BH4 cells.

Authors:  R X Faria; C M Cascabulho; R A M Reis; Luiz Anastácio Alves
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-28       Impact factor: 3.000

3.  Effect of extracellular ATP on the human leukaemic cell line K562 and its multidrug counterpart.

Authors:  Alcira A Bernardo; Flavio Eduardo Pinto-Silva; Pedro M Persechini; Robson Coutinho-Silva; José Roberto Meyer-Fernandes; André Luiz Fonseca de Souza; Vivian M Rumjanek
Journal:  Mol Cell Biochem       Date:  2006-07-06       Impact factor: 3.396

4.  Purinergic receptors are required for HIV-1 infection of primary human macrophages.

Authors:  Joy E Hazleton; Joan W Berman; Eliseo A Eugenin
Journal:  J Immunol       Date:  2012-03-26       Impact factor: 5.422

Review 5.  Anti-CD23.

Authors:  Lanny J Rosenwasser; Jianfeng Meng
Journal:  Clin Rev Allergy Immunol       Date:  2005-08       Impact factor: 8.667

Review 6.  The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Authors:  Guido Beldi; Keiichi Enjyoji; Yan Wu; Lindsay Miller; Yara Banz; Xiaofeng Sun; Simon C Robson
Journal:  Front Biosci       Date:  2008-01-01

7.  Regeneration and tolerance factor prevents bystander T-cell death associated with human immunodeficiency virus infection.

Authors:  Richard A Derks; Kenneth D Beaman
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

8.  Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.

Authors:  A D Michel; E Fonfria
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

9.  Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids.

Authors:  H Jiang; A G Zhu; M Mamczur; J R Falck; K M Lerea; J C McGiff
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

Review 10.  To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question.

Authors:  Serena Janho Dit Hreich; Jonathan Benzaquen; Paul Hofman; Valérie Vouret-Craviari
Journal:  Purinergic Signal       Date:  2021-08-04       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.